Development of alkylating agent-resistant human tumor cell lines

Author:

Teicher Beverly A.,Frei Emil

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Reference60 articles.

1. Begleiter A, Grover J, Froese E, Goldenberg EJ (1983) Membrane transport, sulfhydryl levels and DNA cross-linking in Chinese hamster ovary cell mutants sensitive and resistant to melphalan. Biochem Pharmacol 32:293

2. Behrens BC, Hamilton TC, Masuda H, Grotzinger KR, Whang-Peng J, Louie KG, Knutsen T, McKoy WM, Young RC, Ozols RF (1987) Characterization of a cis-diaminedichloroplatimun (II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues. Cancer Res 47:414

3. Bodell WJ, Gerosa M, Aida T, Berger MS, Rosenblum ML (1985) Investigation of resistance to DNA cross-linking agents in 9L cell lines with different sensitivities to chloroethylnitrosoureas. Cancer Res 45:3460

4. Boon MH, Parsons PG (1984) Cyclophosphamide resistance developed in a human melanoma cell line. Cancer Treat Rep 68:1239

5. Burchenal JH, Kalaher K, Dew K, Lokys L, Gale G (1978) Studies of cross-resistant synergistic combinations and blocking of activity of platinum derivatives. Biochimie 60:961

Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3